VYGR Voyager Therapeutics PE ratio, current and historical analysis
The current PE ratio of VYGR can't be determined, as the TTM EPS of -$1.13 is negative. The last recorded PE ratio for Voyager Therapeutics was 8.48 in September 2024.
VYGR PE ratio history
The average historical PE ratio of Voyager Therapeutics for the last nine years is 6.87. Over the past nine years, VYGR's PE ratio was at its highest in the Jun 2024 quarter at 30.42, when the stock price was $7.91 and the EPS was $0.26. The lowest value was in the Sep 2016 quarter, when it reached 0.79 with a price of $12.01 and an EPS of $15.21.
Voyager Therapeutics PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $5.67 | -$1.13 |
| 2023 | 2.74 | N/A | $8.44 | $3.08 |
| 2022 | N/A | N/A | $6.1 | -$1.21 |
| 2021 | N/A | N/A | $2.71 | -$1.89 |
| 2020 | 7.22 | N/A | $7.15 | $0.99 |
| 2019 | N/A | N/A | $13.95 | -$1.21 |
| 2018 | N/A | N/A | $9.4 | -$2.75 |
| 2017 | N/A | N/A | $16.6 | -$2.64 |
| 2016 | N/A | N/A | $12.74 | -$1.59 |
| 2015 | N/A | N/A | $21.9 | -$9.14 |
| 2014 | N/A | N/A | N/A | -$27.83 |
Voyager Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | N/A | N/A | $5.67 | -$1.13 |
| Sep 2024 | 8.48 | -72.12% | $5.85 | $0.69 |
| Jun 2024 | 30.42 | N/A | $7.91 | $0.26 |
| Mar 2024 | N/A | N/A | $9.31 | -$0.07 |
| Dec 2023 | 2.74 | -53% | $8.44 | $3.08 |
| Sep 2023 | 5.83 | 21.21% | $7.75 | $1.33 |
| Jun 2023 | 4.81 | 48.92% | $11.45 | $2.38 |
| Mar 2023 | 3.23 | N/A | $7.71 | $2.39 |
| Dec 2022 | N/A | N/A | $6.1 | -$1.21 |
| Sep 2022 | N/A | N/A | $5.92 | -$0.45 |
| Jun 2022 | N/A | N/A | $5.91 | -$1.58 |
| Mar 2022 | N/A | N/A | $7.62 | -$1.88 |
| Dec 2021 | N/A | N/A | $2.71 | -$1.89 |
| Sep 2021 | N/A | N/A | $2.63 | -$2.48 |
| Jun 2021 | 8.43 | 89.86% | $4.13 | $0.49 |
VYGR average PE ratio chart
VYGR PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OLMA Olema Pharmaceuticals Inc | N/A | $230.28M |
| OMER Omeros Corp | N/A | $432M |
| ONVO Organovo Holdings Inc | N/A | $3.16M |
| ORIC Oric Pharmaceuticals Inc | N/A | $370.76M |
| ORMP Oramed Pharmaceuticals Inc | N/A | $89.46M |
| VYGR Voyager Therapeutics Inc | N/A | $174.45M |
Frequently asked questions
What is Voyager Therapeutics's PE ratio?
The current price to earnings ratio of VYGR can't be calculated, as its EPS of -$1.13 is negative.
What is the 3-year average PE ratio for Voyager Therapeutics (VYGR)?
The average PE ratio for VYGR stock over the past 3 years is 9.25.
What is the 5-year average PE ratio for Voyager Therapeutics (VYGR)?
The average PE ratio for VYGR stock over the past 5 years is 8.56.
What is the highest PE ratio for VYGR?
The highest quarterly PE ratio in the last nine years has been 30.42 and it was in the Jun 2024 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.